Literature DB >> 33489586

A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.

Takanori Ohta1, Naoki Oda1, Keiko Saito1, Sadafumi Tamiya2, Toshiyuki Ueno1.   

Abstract

A 50-year-old Japanese man complaining of dry mouth and eyes, pale skin with cold irritation, and worsening epigastric pain was admitted to the hospital, whereupon he developed fever and anasarca. A computed tomography (CT) scan showed ascites, hepatosplenomegaly, and mildly enlarged multiple lymph nodes, and blood examination revealed renal impairment, thrombocytopenia, and high levels of C-reactive protein (CRP). He was diagnosed with Sjögren syndrome and concurrently manifested symptoms resembling TAFRO syndrome (i.e., thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O)). Although the TAFRO syndrome-like symptoms progressed, he gradually recovered with immunosuppressive agents. Seven years and five months after the admission, the TAFRO syndrome-like symptoms recurred. Bone marrow biopsy specimens revealed reticulin fibrosis. Inguinal and mediastinal lymph nodes biopsy specimens revealed Castleman disease-like features. Although the symptoms indicated TAFRO syndrome, a diagnosis was not possible owing to the presence of hypergammaglobulinemia and Sjögren syndrome, which required exclusion. Corticosteroid treatment was initiated; however, it was complicated by retroperitoneal hemorrhage, probably due to microangiopathy. After additional treatment with tocilizumab and rituximab, the TAFRO syndrome-like symptoms improved and the hemorrhage progression stopped. In conclusion, TAFRO syndrome-like symptoms may recur with vascular complications and can be successfully treated with tocilizumab and rituximab during Sjögren syndrome. The etiology of TAFRO syndrome could potentially involve Sjögren syndrome, and these syndromes may co-exist.
Copyright © 2020, Ohta et al.

Entities:  

Keywords:  autoimmune diseases; microangiopathy; multicentric castleman disease; retroperitoneal hemorrhage; rituximab; sjögren syndrome; tafro syndrome; tma; tocilizumab

Year:  2020        PMID: 33489586      PMCID: PMC7813549          DOI: 10.7759/cureus.12175

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  20 in total

1.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

2.  Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Authors:  Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Norifumi Tsukamoto; Yasuhito Ishigaki; Nozomu Kurose; Makoto Ide; Jun Murakami; Kenji Nara; Hiroshi Yamamoto; Yoko Ozawa; Hidekazu Takahashi; Katsuhiro Miura; Tsutomu Miyauchi; Shinichirou Yoshida; Akihito Momoi; Nobuyasu Awano; Soichiro Ikushima; Yasunori Ohta; Natsue Furuta; Shino Fujimoto; Haruka Kawanami; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Shigeo Nakamura; Tomohiro Kinoshita; Sadao Aoki
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

3.  Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome.

Authors:  Dong-Fang Lin; Shu-Min Yan; Yan Zhao; Wen Zhang; Meng-Tao Li; Xiao-Feng Zeng; Feng-Chun Zhang; Yi Dong
Journal:  Chin Med J (Engl)       Date:  2010-11       Impact factor: 2.628

4.  Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.

Authors:  Tomomi Matsuyama; Masataka Kuwana; Masanori Matsumoto; Ayami Isonishi; Shigeko Inokuma; Yoshihiro Fujimura
Journal:  Thromb Haemost       Date:  2009-08       Impact factor: 5.249

5.  Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Authors:  Noriko Iwaki; David C Fajgenbaum; Christopher S Nabel; Yuka Gion; Eisei Kondo; Mitsuhiro Kawano; Taro Masunari; Isao Yoshida; Hiroshi Moro; Koji Nikkuni; Kazue Takai; Kosei Matsue; Mitsutoshi Kurosawa; Masao Hagihara; Akio Saito; Masataka Okamoto; Kenji Yokota; Shinichiro Hiraiwa; Naoya Nakamura; Shinji Nakao; Tadashi Yoshino; Yasuharu Sato
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

Review 6.  Autoimmune myelofibrosis: report of three cases and review of the literature.

Authors:  Rita Rizzi; Domenico Pastore; Arcangelo Liso; Grazia M Liuzzi; Anna M Dalena; Giorgina Specchia; Rosalia Ricco; Vincenzo Liso
Journal:  Leuk Lymphoma       Date:  2004-03

Review 7.  Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.

Authors:  Taku Kikuchi; Takayuki Shimizu; Takaaki Toyama; Ryohei Abe; Shinichiro Okamoto
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

8.  Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.

Authors:  Hanako Tsurumi; Yoshihide Fujigaki; Tadashi Yamamoto; Risa Iino; Kei Taniguchi; Michito Nagura; Shigeyuki Arai; Yoshifuru Tamura; Tatsuru Ota; Shigeru Shibata; Fukuo Kondo; Nozomu Kurose; Yasufumi Masaki; Shunya Uchida
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

9.  TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.

Authors:  Céline Louis; Sandrine Vijgen; Kaveh Samii; Yves Chalandon; Louis Terriou; David Launay; David C Fajgenbaum; Jörg D Seebach; Yannick D Muller
Journal:  Front Med (Lausanne)       Date:  2017-09-22

10.  Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.

Authors:  Shino Fujimoto; Hiroshi Kawabata; Nozomu Kurose; Haruka Kawanami-Iwao; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Yasufumi Masaki
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more
  1 in total

1.  Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?

Authors:  Yoshito Nishimura; Asami Nishikori; Haruki Sawada; Torrey Czech; Yuki Otsuka; Midori Filiz Nishimura; Hiroki Mizuno; Naoki Sawa; Shuji Momose; Kumiko Ohsawa; Fumio Otsuka; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.